TWiV 1014: Clinical update with Dr. Daniel Griffin

June 10, 2023

In his weekly clinical update, Dr. Griffin discusses estimates of SARS-CoV-2 seroprevalence and incidence of primary SARS-CoV-2 infections among blood donors, by COVID-19 vaccination status, smart thermometer–based participatory surveillance to discern the role of children in household viral transmission during the COVID-19 pandemic, COVID-19 vaccine mandates, changing severity and epidemiology of adults hospitalized with COVID-19 in the United States after introduction of COVID-19 vaccines, effectiveness of COVID-19 treatment with Nirmatrelvir–Ritonavir or Molnupiravir among U.S. veterans, national trends in anticoagulation therapy for COVID-19 hospitalized adults in the United States, development of a definition of postacute sequelae of SARS-CoV-2 infection, neuroinflammation after COVID-19 with persistent depressive and cognitive symptoms, long COVID clinical phenotypes up to six months after infection identified by latent class analysis of self-reported symptoms, and coronary microvascular health in symptomatic patients with prior COVID-19 infection.

Click arrow to play
Download TWiV 1014 (24 MB .mp3, 40 min)

Subscribe (free): Apple PodcastsGoogle PodcastsRSSemail

Become a patron of TWiV!

  • Estimates of SARS-CoV-2 seroprevalence and incidence of infections among blood donors, by vaccination status (CDC) 1:39
  • Smart thermometer–based surveillance to discern the role of children in household viral transmission during the COVID-19 pandemic (JAMA) 3:50
  • COVID-19 vaccine mandates (GOV) 10:06
  • Changing epidemiology of adults hospitalized with COVID-19 after introduction of vaccines (CID) 11:47
  • Effectiveness of COVID-19 treatment with Nirmatrelvir–Ritonavir or Molnupiravir among U.S. Veterans (ACP Journals) 15:00
  • National trends in Anticoagulation therapy for COVID-19 (IDSA) 18:41
  • Development of a definition of postacute sequelae of SARS-CoV-2 infection (JAMA) 21:04
  • Neuroinflammation after COVID-19 with depressive and cognitive symptoms (JAMA) 25:35
  • Long COVID clinical phenotypes up to six months after infection identified by latent class analysis of self-reported symptoms (OFID) 27:24
  • Coronary microvascular health in patients with prior COVID-19 infection (EACVI) 29:57
  • Contribute to our FIMRC fundraiser at PWB 31:30
  • Letters read on TWiV 1014 32:00
  • Dr. Griffin’s COVID treatment summary (pdf)
  • Timestamps by Jolene. Thanks!

Intro music is by Ronald Jenkees

Send your questions for Dr. Griffin to daniel@microbe.tv

Leave a Reply

Your email address will not be published. Required fields are marked *